Our ESRP1 promoter-driven reporter system directly addressed this gap, providing a functional cellular model to study ESRP1 promoter demethylation and significant potential for HTS of compounds targeting DNMT-mediated ESRP1 silencing in RCC. This evidence concerns the gene ESRP1 and renal cell carcinoma.